This website is not owned by Johnson & Johnson (New Zealand) Ltd, and we do not review or control the content of this website. Products discussed on this website may not be approved for use or may be approved for different indications in your country. Before using any medical device, review all relevant Instructions for Use, Package Inserts or Summary of Product Characteristics. We do not endorse the use or promotion of unapproved products or indications. Any demonstrations of approved medical devices should be considered as information only and are not a surgical training guide.
Features & Benefits

Designed for Definition
Designed to create high density, high definition maps and precise anatomical maps with minimal catheter manipulation.

Signal Mapping
Map signals and validate termination of signals in atrial tachycardia, ventricular tachycardia, and complex fractionated electrograms in atrial fibrillation.
©2021 Johnson & Johnson (New Zealand) Ltd. This site is published by Johnson & Johnson (New Zealand) Ltd which is solely responsible for its contents. This site is intended for Healthcare Professionals from New Zealand only. Biosense Webster is a business unit of Johnson & Johnson (New Zealand) Ltd. 507 Mount Wellington Highway, Mount Wellington, Auckland, 1060, New Zealand.